05/10/2024 9:37 AM | Kiromic BioPharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024 4:29 PM | Kiromic BioPharma (Issuer) Mirandola Leonardo (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/09/2024 4:00 PM | BERSANI PIETRO (Filed by) Kiromic BioPharma (Subject)
| Form SC 13D/A | |
05/07/2024 5:17 PM | Hungerford Brian (Reporting) Kiromic BioPharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 4:30 PM | Kiromic BioPharma (Filer)
| Form PRE 14A | |
05/07/2024 4:00 PM | BERSANI PIETRO (Reporting) Kiromic BioPharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/06/2024 3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
04/19/2024 3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2024 3:30 PM | Kiromic BioPharma (Filer)
| Form RW | |
04/05/2024 3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/21/2024 4:21 PM | Kiromic BioPharma (Filer)
| Form 10-K/A | |
03/20/2024 4:58 PM | Catlin Michael (Reporting) Kiromic BioPharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 4:55 PM | Kiromic BioPharma (Issuer) NAGEL MICHAEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 4:57 PM | Kiromic BioPharma (Issuer) Misajon Pamela (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 8:56 PM | Kiromic BioPharma (Subject) YA II PN, Ltd. (Filed by)
| Form SC 13G/A | |
01/11/2024 3:15 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 9:25 AM | Empery Asset Management, LP (Filed by) Kiromic BioPharma (Subject)
| Form SC 13G/A | |
11/20/2023 7:46 AM | Kiromic BioPharma (Subject) Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
11/09/2023 8:49 AM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2023 3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/06/2023 3:05 PM | Hungerford Brian (Reporting) Kiromic BioPharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/06/2023 3:06 PM | Catlin Michael (Reporting) Kiromic BioPharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/06/2023 3:07 PM | Kiromic BioPharma (Issuer) NAGEL MICHAEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/06/2023 3:07 PM | Kiromic BioPharma (Issuer) Misajon Pamela (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/06/2023 3:08 PM | BERSANI PIETRO (Reporting) Kiromic BioPharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2023 3:05 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/13/2023 3:45 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/29/2023 3:15 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2023 3:52 PM | Kiromic BioPharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023 11:28 AM | Catlin Michael (Reporting) Kiromic BioPharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/02/2023 5:31 PM | Kiromic BioPharma (Issuer) Misajon Pamela (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
07/24/2023 2:53 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/19/2023 3:15 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/18/2023 3:21 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/18/2023 3:22 PM | Kiromic BioPharma (Filer)
| Form DEFA14A | |
06/29/2023 3:33 PM | Kiromic BioPharma (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
06/27/2023 3:15 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/16/2023 4:23 PM | Kiromic BioPharma (Filer)
| Form DEF 14A | |
06/12/2023 3:22 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/30/2023 3:16 PM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
This consistently signaled gains of 453%... 610%... and even 1036%... (Ad) It doesn’t happen often, but occasionally, something completely unique comes across my radar.
In this case, I’m talking about legal “Insider Trading”.
Traders who have consistently signaled 453% … 610% .. and even 1036%... gains.
And until now they have been doing it completely under the radar.
In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade. Register for the imminent briefing here. |
05/22/2023 9:31 AM | Kiromic BioPharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/21/2023 11:15 PM | Kiromic BioPharma (Filer)
| Form EFFECT | |
05/19/2023 3:49 PM | Kiromic BioPharma (Filer)
| Form 424B3 | |